联系我们

注: * 为必填选项,请确保全部填完进行提交
首页 > 产品详情 > 气体控制 > 动物低氧高氧实验

动物低氧高氧实验系统

产品型号:

OX-100

详细介绍:

Ox-100系列产品主要用于动物常压低氧、高氧、间歇式低氧等实验,采用分体式设计,由气体控制器和动物氧舱组成。操作简单,精准控制。可实时监测温度、湿度、氧气浓度、二氧化碳浓度等参数, 具有多种控氧模式... 查看详情 >
留言购买

产品描述

塔望科技提供全系列的动物实验用低/高氧控制产品,包括恒定浓度控制的低氧动物箱、高氧动物箱、可编程的间歇氧浓度控制系统、带缓冲舱的手套低氧箱等。整套低氧/高氧实验箱装置主要由氧气控制器和动物实验箱两部分组成。另可提供多种不同的气体控制器,满足不同实验O2、CO2、NO、CO、O3等气体浓度控制的需求。

Ox-100动物低氧实验系统可以控制动物实验箱内持续低氧的环境,用以制造相关的低氧实验模型。用户可自由设置所需要的浓度和实验持续时间,所有的设置通过控制主机触摸屏完成,人性化设计,操作简便。

Ox-100动物低氧实验系统监测指标全面,动物低氧舱内具有集成化的传感器模块,内置温度、湿度、氧气、二氧化碳传感器。可以实时监测动物低氧舱内的环境。系统通过闭环反馈控制,根据动物低氧舱内的氧浓度实时反馈控制,使动物实验低氧数据更准确,避免了控制型浓度输出和低氧舱内浓度不一致的情况。Ox-100动物低氧实验系统具有优良的控制性能,持续低氧实验时,氧浓度的误差为0.1%

Ox-100动物低氧实验系统提供不同尺寸的动物低氧箱,默认低氧箱可放置1个大鼠笼(或2个小鼠笼),同时提供大号规格,可容纳2个大鼠笼和4个大鼠笼。如需其它规格,可提供定制。

如需高氧实验,请选择型号Ox-100HE

 

产品特点及参数

1. 为动物低氧实验模型的建立提供稳定的低氧环境

2. 按照设定气体浓度自动配比气体,维持恒定的氧气浓度环境。无需在箱体外混合比例气体,实验氧浓度的准确,节省气源

3. 舱体采用全透明PMMA材质,防止由于光线影响动物生物节律

4. 7英寸大屏触摸屏控制,人性化界面,操作简单

5. 监测参数:温度、湿度、氧气O2浓度、二氧化碳浓度

6. 控制精度:±0.1%

7. 非色散红外(NDIR)二氧化碳传感器,测量范围:05000ppm

8. 进口电化学氧气O2浓度检测器,测量范围:0-25%vol,线性度好,检测准确、使用寿命长。具有温度补偿机制

9. 温度检测:进口高精度温度传感器

10. 氧气浓度变化动态曲线,直观了解氧气浓度变化的过程

11. 具有定时功能,实验完成,自动恢复常氧状态,并伴有声音提示

12. 氧气浓度自动校准:通过控制器对传感器快速校准

13. 特有的气体混合及循环机制,保证箱体内气体浓度的均一

14. 高性能电磁阀,性能稳定,超长寿命

15. 舱体尺寸有多种选择,可灵活搭配。也可根据实验要求进行定制



ProOx-100动物间歇低氧实验系统多功能控制

可进行间歇低氧实验(CIH)、急性缺氧实验、慢性缺氧实验、高氧/低氧交替实验



动物低氧高氧实验系统(图1)

 

 








应用领域

肺动脉高压、肾脏疾病研究、肿瘤研究、心血管疾病研究、视网膜病变、运动医学研究、OSAHS、脑发育与神经生物学、干细胞研究、医学研究等

 


型号说明

名称

型号

说明

单位

动物低氧实验系统

Ox-100

恒定氧控制,低氧

 套

动物氧浓度实验系统

Ox-100HE

恒定氧控制,低氧/高氧

 套

动物间歇低氧实验系统

ProOx-100

恒定氧控制/间歇氧控制,低氧

 套

动物间歇氧浓度实验系统

ProOx-100HE

恒定氧控制/间歇氧控制,低氧/高氧

 套

 



舱体型号(可选择不同尺寸的低氧舱)

名称

型号

说明

单位

动物实验舱体小号

OxC-S

大鼠笼x1

动物实验舱体中号

OxC-M

大鼠笼x2

动物实验舱体大号

OxC-L

大鼠笼x4

动物实验舱体特大号

OxC-XL

大鼠笼x8

动物实验舱体-CIH

OxC-CIH

36只小鼠

手套操作箱

Gl-700

700L



使用客户名单

图片4.png














相关文献

[1]Ma Jinqiu,Wang Chenyun,Sun Yunbo,Pang Lulu,Zhu Siqing,Liu Yijing,Zhu Lin,Zhang Shouguo,Wang Lin,Du Lina. "Comparative study of oral and intranasal puerarin for prevention of brain injury induced by acute high-altitude hypoxia" . [J] International Journal of Pharmaceutics,2020,591


[2]Guijuan Chen,Kang Cheng,Yun Niu,Li Zhu,Xueting Wang."Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling" . [J]. Archives of Biochemistry and Biophysics ,Volume 729, 109393;


[3]Yapeng,LuPanpanChang,WangwangDing,JiangpeiBian,DanWang,XuetingWang,QianqianLuo,XiaomeiWu,LiZhu."Pharmacological inhibition of mitochondrial division attenuates simulated high-altitude exposure-induced cerebral edema in mice: Involvement of inhibition of the NF-κB signaling pathway in glial cells". [J]. European Journal of Pharmacology,Volume 929,2022,175137


[4]Jun-Yu Wei, Miao-Yue Hu, Xiu-Qi Chen, Feng-Ying Lei, Jin-Shuang Wei, Jie Chen, Xuan-Kai Qin & Yuan-Han Qin ."Rosiglitazone attenuates hypoxia-induced renal cell apoptosis by inhibiting NF-κB signaling pathway in a PPARγ-dependent manner" . [J]. European Journal of Pharmacology,Renal Failure, 44:1, 2056-2065


[5]Yilan Wang, Zherui Shen, Caixia Pei, Sijing Zhao, Nan Jia, Demei Huang, Xiaomin Wang, Yongcan Wu, Shihua Shi, Yacong He, Zhenxing Wang,"Eleutheroside B ameliorated high altitude pulmonary edema by attenuating ferroptosis and necroptosis through Nrf2-antioxidant response signaling" . [J]. Biomedicine & Pharmacotherapy, Volume 156, 2022,113982


[6]Fang Zhao, Yan Meng, Yue Wang, Siqi Fan, Yu Liu,Xiangfeng Zhang, Chenyang Ran, Hongxin Wang and Meili Lu. "Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway" .[J]. Frontiers in Pharmacology,10.3389/fphar.2022.920977


[7]Xu Y, Kong X, Li J, Cui T, Wei Y, Xu J, Zhu Y , Zhu X. “Mild Hypoxia Enhances the Expression of HIF and VEGF and Triggers the Response to Injury in Rat Kidneys.” [J]. Front. Physiol. 12:690496. doi: 10.3389/fphys.2021.690496


[8]Liang Xie, Qinhan Wu, Weiping Hu, Xu Wu, Guiling Xiang, Shengyu Hao, Han Guo, Shanqun Li. “Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions.” [J]. Psychopharmacology. 


[9]Li Huang, Tianyou Li, Min Zhou, Mengyan Deng, Lidong Zhang, Long Yi, Jundong Zhu, Xiaohui Zhu, Mantian Mi. “Hypoxia Improves Endurance Performance by Enhancing Short Chain Fatty Acids Production via Gut Microbiota Remodeling.” [J]. Front. Microbiol. 12:820691


[10]Yanhong Pei a b, Lifei Huang c, Tong Wang c, Qinhan Yao a, Yanrong Sun a, Yan Zhang a, Xiaomei Yang a, Jiliang Zhai d, Lihua Qin a, Jiajia Xue c, Xing Wang c, Hongquan Zhang a b, Junhao Yan."Bone marrow mesenchymal stem cells loaded into hydrogel/nanofiber composite scaffolds ameliorate ischemic brain injury. materialstoday ADVANCES, Volume 17, March 2023, 100349.


[11]Zhang, C., Sun, Y., Guo, Y. et al. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension. “[J].Cell Death Discov. 9, 98 (2023).


[12]Fang Zhao, Yan Meng, Yue Wang, Siqi Fan, Yu Liu,Xiangfeng Zhang, Chenyang Ran, Hongxin Wang and Meili Lu. "Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway" .[J]. Frontiers in Pharmacology,10.3389/fphar.2022.920977


[13]Chenyu Xu, Jun Xu, Chunfang Zou, Qian Li, Shan Mao, Ying Shi, Yan Tan, Wei Gu, Liang Ye. "Chronic Intermittent Hypoxia Regulates CaMKII-Dependent MAPK Signaling to Promote the Initiation of Abdominal Aortic Aneurysm."  [J]. Hindawi, Oxidative Medicine and Cellular Longevity Volume 2021, Article ID 2502324, 15 pages


[14]Jing Zhang, Jian-Zhong Jiang, Jun Xu, Chen-Yu Xu, Shan Mao, Ying Shi, Wei Gu, Chun-Fang Zou, Yue-Ming Zhao,  Liang Ye. "Identification of Novel Biomarkers for Abdominal Aortic Aneurysm Promoted by Obstructive Sleep Apnea." [J].  Elsevier Inc. This is an open access article under the CC BY-NC-ND license


[15]Zhang Q, Xu L, Bai Y, Chen P, Xing M, Cai F, Wu Y,  Song W. “Intermittent hypoxia-induced enhancement of sociability and working memory associates with CNTNAP2 upregulation.” [J]. Front. Mol. Neurosci. 16:1155047.


[16]Chen Zhang, Yue Sun, Yingying Guo, Jingjing Xu, Haiyan Zhao. “JMJD1C promotes smooth muscle cell proliferation by activating glycolysis in pulmonary arterial hypertension.” [J]. Cell Death Discovery (2023) 9:98.




*我公司可提供3Q验证,根据客户的特殊应用、特殊需求提供功能定制服务,也可以提供相关的实验服务,详情请来电咨询。